These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 16873543)

  • 1. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity.
    Lin EJ; Sainsbury A; Lee NJ; Boey D; Couzens M; Enriquez R; Slack K; Bland R; During MJ; Herzog H
    Endocrinology; 2006 Nov; 147(11):5094-101. PubMed ID: 16873543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M; Ghibaudi L; Gao J; Hwa JJ
    Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
    Lin EJ; Young D; Baer K; Herzog H; During MJ
    Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice: chronic intracerebroventricular infusion of D-Trp(34)NPY.
    Mashiko S; Ishihara A; Iwaasa H; Sano H; Oda Z; Ito J; Yumoto M; Okawa M; Suzuki J; Fukuroda T; Jitsuoka M; Morin NR; MacNeil DJ; Van der Ploeg LH; Ihara M; Fukami T; Kanatani A
    Endocrinology; 2003 May; 144(5):1793-801. PubMed ID: 12697685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective activation of central NPY Y1 vs. Y5 receptor elicits hyperinsulinemia via distinct mechanisms.
    Gao J; Ghibaudi L; Hwa JJ
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E706-11. PubMed ID: 15187000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hypothalamic neuropeptide Y in feeding and obesity.
    Gehlert DR
    Neuropeptides; 1999 Oct; 33(5):329-38. PubMed ID: 10657510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis.
    Allison SJ; Baldock PA; Enriquez RF; Lin E; During M; Gardiner EM; Eisman JA; Sainsbury A; Herzog H
    J Bone Miner Res; 2009 Feb; 24(2):294-304. PubMed ID: 18847327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats.
    Rojas JM; Stafford JM; Saadat S; Printz RL; Beck-Sickinger AG; Niswender KD
    Am J Physiol Endocrinol Metab; 2012 Dec; 303(12):E1479-88. PubMed ID: 23074243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Y2Y4 receptor double knockout protects against obesity due to a high-fat diet or Y1 receptor deficiency in mice.
    Sainsbury A; Bergen HT; Boey D; Bamming D; Cooney GJ; Lin S; Couzens M; Stroth N; Lee NJ; Lindner D; Singewald N; Karl T; Duffy L; Enriquez R; Slack K; Sperk G; Herzog H
    Diabetes; 2006 Jan; 55(1):19-26. PubMed ID: 16380472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.
    Baldock PA; Sainsbury A; Allison S; Lin EJ; Couzens M; Boey D; Enriquez R; During M; Herzog H; Gardiner EM
    J Bone Miner Res; 2005 Oct; 20(10):1851-7. PubMed ID: 16160743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of diabetic hyperphagia in neuropeptide Y--deficient mice.
    Sindelar DK; Mystkowski P; Marsh DJ; Palmiter RD; Schwartz MW
    Diabetes; 2002 Mar; 51(3):778-83. PubMed ID: 11872679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system.
    Hökfelt T; Broberger C; Zhang X; Diez M; Kopp J; Xu Z; Landry M; Bao L; Schalling M; Koistinaho J; DeArmond SJ; Prusiner S; Gong J; Walsh JH
    Brain Res Brain Res Rev; 1998 May; 26(2-3):154-66. PubMed ID: 9651513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuropeptide Y Y1 receptor mediates NPY-induced inhibition of the gonadotrope axis under poor metabolic conditions.
    Gonzales C; Voirol MJ; Giacomini M; Gaillard RC; Pedrazzini T; Pralong FP
    FASEB J; 2004 Jan; 18(1):137-9. PubMed ID: 14597564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism.
    Raposinho PD; Pierroz DD; Broqua P; White RB; Pedrazzini T; Aubert ML
    Mol Cell Endocrinol; 2001 Dec; 185(1-2):195-204. PubMed ID: 11738809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic neuropeptide Y infusion into the lateral ventricle induces sustained feeding and obesity in mice lacking either Npy1r or Npy5r expression.
    Raposinho PD; Pedrazzini T; White RB; Palmiter RD; Aubert ML
    Endocrinology; 2004 Jan; 145(1):304-10. PubMed ID: 14525913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice.
    Kushi A; Sasai H; Koizumi H; Takeda N; Yokoyama M; Nakamura M
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15659-64. PubMed ID: 9861026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors.
    Jain MR; Pu S; Kalra PS; Kalra SP
    Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.
    Chu DQ; Cox HM; Costa SK; Herzog H; Brain SD
    Br J Pharmacol; 2003 Sep; 140(2):422-30. PubMed ID: 12970079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference of NPY and its receptor gene expressions between obesity and obesity-resistant rats in response to high-fat diet.
    Wang C; Yang N; Wu S; Liu L; Sun X; Nie S
    Horm Metab Res; 2007 Apr; 39(4):262-7. PubMed ID: 17447163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.
    Lee EW; Michalkiewicz M; Kitlinska J; Kalezic I; Switalska H; Yoo P; Sangkharat A; Ji H; Li L; Michalkiewicz T; Ljubisavljevic M; Johansson H; Grant DS; Zukowska Z
    J Clin Invest; 2003 Jun; 111(12):1853-62. PubMed ID: 12813021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.